For the April 12, 2016 meeting of the FDA's Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
- SABRIL Labeling, 9/18/2015
- SABRIL Safety and Drug Utilization Review
- Pediatric Focused Safety Review: Sabril (vigabatrin)
- SABRIL Clinical Review
- SABRIL Clinical Pharmacology Review
- SABRIL Statistical Review